| Literature DB >> 31181585 |
José Carlos Peraçoli1, Vera Therezinha Medeiros Borges1, José Geraldo Lopes Ramos2, Ricardo de Carvalho Cavalli3, Sérgio Hofmeister de Almeida Martins Costa2, Leandro Gustavo de Oliveira1, Francisco Lazaro Pereira de Souza4, Henri Augusto Korkes5, Ione Rodrigues Brum6, Maria Laura Costa7, Mário Dias Corrêa Junior8, Nelson Sass9, Angélica Lemos Debs Diniz10, Caio Antonio de Campos Prado3, Edson Viera da Cunha Filho11.
Abstract
Pre-eclampsia is a multifactorial and multisystemic disease specific to gestation. It is classically diagnosed by the presence of hypertension associated with proteinuria manifested in a previously normotensive pregnant woman after the 20th week of gestation. Pre-eclampsia is also considered in the absence of proteinuria if there is target organ damage. The present review takes a general approach focused on aspects of practical interest in the clinical and obstetric care of these women. Thus, it explores the still unknown etiology, current aspects of pathophysiology and of the diagnosis, the approach to disease prediction, its adverse outcomes and prevention. Management is based on general principles, on nonpharmacological and on pharmacological clinical treatment of severe or nonsevere situations with emphasis on the hypertensive crisis and eclampsia. Obstetric management is based on preeclampsia without or with signs of clinical and/or laboratory deterioration, stratification of gestational age in < 24 weeks, between 24 and less than 34 weeks, and ≥ 34 weeks of gestation, and guidance on route of delivery. An immediate puerperium approach and repercussions in the future life of pregnant women who develop preeclampsia is also presented. Thieme Publicações Ltda Rio de Janeiro, Brazil.Entities:
Mesh:
Year: 2019 PMID: 31181585 DOI: 10.1055/s-0039-1687859
Source DB: PubMed Journal: Rev Bras Ginecol Obstet ISSN: 0100-7203